Skip to main content
. 2020 Feb 7;28(1):3–11. doi: 10.3727/096504019X15509383469698

Figure 1.

Figure 1

The vasohibin2 (VASH2) expression in non-small cell lung cancer (NSCLC) tissues. (A) qPCR was performed to measure the expression of VASH2 in NSCLC tissues and the matched adjacent tissues (n = 200). (B) The Kaplan–Meier survival curve showed the survival rate in patients with high VASH2 expression (n = 116) and those with low VASH2 expression (n = 84).